Brandon A Sherrod1, Samuel G McClugage2, Vincent E Mortellaro3, Inmaculada B Aban4, Brandon G Rocque2. 1. Department of Neurosurgery, Division of Pediatric Neurosurgery, The University of Alabama at Birmingham and Children's Hospital of Alabama, Birmingham, AL. Electronic address: bsherrod@uab.edu. 2. Department of Neurosurgery, Division of Pediatric Neurosurgery, The University of Alabama at Birmingham and Children's Hospital of Alabama, Birmingham, AL. 3. Department of Surgery, Division of Pediatric Surgery, The University of Alabama at Birmingham and Children's Hospital of Alabama, Birmingham, AL. 4. Department of Biostatistics, The University of Alabama at Birmingham, School of Public Health, Birmingham, AL.
Abstract
PURPOSE: To evaluate venous thromboembolism (VTE) rates and risk factors following inpatient pediatric surgery. METHODS: 153,220 inpatient pediatric surgical patients were selected from the 2012-2015 NSQIP-P database. Demographic and perioperative variables were documented. Primary outcome was VTE requiring treatment within 30 postoperative days. Secondary outcomes included length of stay (LOS) and 30-day mortality. Prediction models were generated using logistic regression. Mortality and time to VTE were assessed using Kaplan-Meier survival analysis. RESULTS: 305 patients (0.20%) developed 296 venous thromboses and 12 pulmonary emboli (3 cooccurrences). Median time to VTE was 9 days. Most VTEs (81%) occurred predischarge. Subspecialties with highest VTE rates were cardiothoracic (0.72%) and general surgery (0.28%). No differences were seen for elective vs. urgent/emergent procedures (p = 0.106). All-cause mortality VTE patients was 1.2% vs. 0.2% in patients without VTE (p < 0.001). After stratifying by American Society of Anesthesiologists (ASA) class, no mortality differences remained when ASA < 3. Preoperative, postoperative, and total LOSs were longer for patients with VTE (p < 0.001 for each). ASA ≥ 3, preoperative sepsis, ventilator dependence, enteral/parenteral feeding, steroid use, preoperative blood transfusion, gastrointestinal disease, hematologic disorders, operative time, and age were independent predictors (C-statistic = 0.83). CONCLUSIONS: Pediatric postsurgical patients have unique risk factors for developing VTE. LEVEL OF EVIDENCE: Level II.
PURPOSE: To evaluate venous thromboembolism (VTE) rates and risk factors following inpatient pediatric surgery. METHODS: 153,220 inpatient pediatric surgical patients were selected from the 2012-2015 NSQIP-P database. Demographic and perioperative variables were documented. Primary outcome was VTE requiring treatment within 30 postoperative days. Secondary outcomes included length of stay (LOS) and 30-day mortality. Prediction models were generated using logistic regression. Mortality and time to VTE were assessed using Kaplan-Meier survival analysis. RESULTS: 305 patients (0.20%) developed 296 venous thromboses and 12 pulmonary emboli (3 cooccurrences). Median time to VTE was 9 days. Most VTEs (81%) occurred predischarge. Subspecialties with highest VTE rates were cardiothoracic (0.72%) and general surgery (0.28%). No differences were seen for elective vs. urgent/emergent procedures (p = 0.106). All-cause mortality VTE patients was 1.2% vs. 0.2% in patients without VTE (p < 0.001). After stratifying by American Society of Anesthesiologists (ASA) class, no mortality differences remained when ASA < 3. Preoperative, postoperative, and total LOSs were longer for patients with VTE (p < 0.001 for each). ASA ≥ 3, preoperative sepsis, ventilator dependence, enteral/parenteral feeding, steroid use, preoperative blood transfusion, gastrointestinal disease, hematologic disorders, operative time, and age were independent predictors (C-statistic = 0.83). CONCLUSIONS: Pediatric postsurgical patients have unique risk factors for developing VTE. LEVEL OF EVIDENCE: Level II.
Authors: Mehul V Raval; Peter W Dillon; Jennifer L Bruny; Clifford Y Ko; Bruce L Hall; R Lawrence Moss; Keith T Oldham; Karen E Richards; Charles D Vinocur; Moritz M Ziegler Journal: J Am Coll Surg Date: 2010-10-29 Impact factor: 6.113
Authors: Mehul V Raval; Peter W Dillon; Jennifer L Bruny; Clifford Y Ko; Bruce L Hall; R Lawrence Moss; Keith T Oldham; Karen E Richards; Charles D Vinocur; Moritz M Ziegler Journal: J Pediatr Surg Date: 2011-01 Impact factor: 2.545
Authors: Emad H Ibrahim; Manuel Iregui; Donna Prentice; Glenda Sherman; Marin H Kollef; William Shannon Journal: Crit Care Med Date: 2002-04 Impact factor: 7.598
Authors: Selwyn O Rogers; Ravi K Kilaru; Patrick Hosokawa; William G Henderson; Michael J Zinner; Shukri F Khuri Journal: J Am Coll Surg Date: 2007-06 Impact factor: 6.113
Authors: Shannon C Walker; C Buddy Creech; Henry J Domenico; Benjamin French; Daniel W Byrne; Allison P Wheeler Journal: Pediatrics Date: 2021-05-19 Impact factor: 9.703
Authors: Kyle O Rove; Andrew C Strine; Duncan T Wilcox; Gino J Vricella; Timothy P Welch; Brian VanderBrink; David I Chu; Rajeev Chaudhry; Rebecca S Zee; Megan A Brockel Journal: BMJ Open Date: 2020-11-23 Impact factor: 2.692
Authors: Meredith A Achey; Uttara P Nag; Victoria L Robinson; Christopher R Reed; Gowthami M Arepally; Jerrold H Levy; Elisabeth T Tracy Journal: Clin Appl Thromb Hemost Date: 2020 Jan-Dec Impact factor: 2.389
Authors: Elizabeth T Stephens; Anh Thy H Nguyen; Julie Jaffray; Brian Branchford; Ernest K Amankwah; Neil A Goldenberg; E Vincent S Faustino; Neil A Zakai; Amy Stillings; Emily Krava; Guy Young; John H Fargo Journal: Res Pract Thromb Haemost Date: 2022-10-13